Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$8282.0.

  • Cumberland Pharmaceuticals' Income from Non-Controlling Interests fell 21645.11% to -$8282.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9456.0, marking a year-over-year decrease of 13595.85%. This contributed to the annual value of $36055.0 for FY2024, which is 17008.32% up from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Income from Non-Controlling Interests stood at -$8282.0, which was down 21645.11% from $5533.0 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Income from Non-Controlling Interests high stood at $43791.0 for Q1 2024, and its period low was -$36561.0 during Q4 2021.
  • Its 5-year average for Income from Non-Controlling Interests is -$10633.4, with a median of -$13921.0 in 2023.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first plummeted by 47301.24% in 2022, then soared by 32007.74% in 2024.
  • Over the past 5 years, Cumberland Pharmaceuticals' Income from Non-Controlling Interests (Quarter) stood at -$36561.0 in 2021, then skyrocketed by 48.07% to -$18985.0 in 2022, then skyrocketed by 60.07% to -$7581.0 in 2023, then soared by 128.72% to $2177.0 in 2024, then plummeted by 480.43% to -$8282.0 in 2025.
  • Its Income from Non-Controlling Interests stands at -$8282.0 for Q3 2025, versus $5533.0 for Q2 2025 and -$8884.0 for Q1 2025.